Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)
Clinical trial NCT04811339 · COMPLETED
Trial details
- NCT number
- NCT04811339
- Sponsor
- University of Cincinnati
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2021-08-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.